GASTRIC CANCER

>

Latest News

GEN-001/Avelumab Combination Induces Antitumor Activity in Gastric and GEJ Cancer
GEN-001/Avelumab Combination Induces Antitumor Activity in Gastric and GEJ Cancer

May 19th 2023

According to interim phase 2 results, GEN-001 in combination with avelumab has a significant objective response rate in patients with gastric and gastroesophageal junction adenocarcinoma.

Phase 1 Study of PT886 Doses First Patient With Gastric/GEJ/Pancreatic Cancer
Phase 1 Study of PT886 Doses First Patient With Gastric/GEJ/Pancreatic Cancer

March 28th 2023

Pembrolizumab Plus Chemo Emerges as New Option for Advanced, HER2–Negative Gastric/GEJ Cancer
Pembrolizumab Plus Chemo Emerges as New Option for Advanced, HER2–Negative Gastric/GEJ Cancer

February 23rd 2023

Zolbetuximab and mFOLFOX6  Survival in CLDN18.2+ Advanced Gastric/GEJ Adenocarcinoma
Zolbetuximab and mFOLFOX6 Survival in CLDN18.2+ Advanced Gastric/GEJ Adenocarcinoma

January 20th 2023

Shah Explores Treatment Options for Patients With Advanced HER2+ Gastric Cancer
Shah Explores Treatment Options for Patients With Advanced HER2+ Gastric Cancer

December 15th 2022

Video Series
Video Interviews

More News